meglumine has been researched along with Pituitary Neoplasms in 20 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 2 (10.00) | 18.7374 |
| 1990's | 16 (80.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (5.00) | 24.3611 |
| 2020's | 1 (5.00) | 2.80 |
| Authors | Studies |
|---|---|
| Carmichael, JD; Hurth, K; Liu, CJ; Patel, V; Shiroishi, MS; Toga, AW; Zada, G | 1 |
| Byun, HS; Choi, JW; Jeon, P; Kim, HJ; Kim, KH; Kim, ST; Lee, HB | 1 |
| Kuuliala, I | 1 |
| Ishii, Y; Koshimoto, Y; Maeda, M; Naiki, H; Nakakuki, K | 1 |
| Haughton, VM; Lindsey, RO; Prost, R; Yetkin, FZ | 1 |
| Gealy, R; Levitan, ES; Takimoto, K; Trimmer, JS | 1 |
| Ahmadi, J; Hinton, DR; Meyers, GS; Segall, HD; Sharma, OP | 1 |
| Brunberg, JA; Chandler, WF; Eldevik, OP; Hald, JK | 1 |
| Herold, CJ; Knosp, E; Kramer, J; Math, G; Mostbeck, G; Steiner, E | 1 |
| Colombo, N; Loli, P; Scialfa, G; Vignati, F | 1 |
| Ikeda, H; Kobayashi, S; Yoshimoto, T | 1 |
| Bishop, JE; George, S; Keller, MA; Kucharczyk, W; Plewes, DB | 1 |
| Arita, K; Eguchi, K; Kurisu, K; Mukada, K; Sumida, M; Uozumi, T | 1 |
| Bakke, SJ; Hald, JK; Nakstad, PH; Skalpe, IO | 1 |
| Finelli, DA; Kaufman, B | 1 |
| Aguzzi, A; Sartoretti-Schefer, S; Valavanis, A; Wichmann, W | 1 |
| Burman, P; Edén Engström, B; Karlsson, FA; Lundin, P | 1 |
| Ahmadi, J; Apuzzo, ML; Destian, S; Segall, HD; Zee, CS | 1 |
| Kawamura, J; Keyaki, A; Kuroda, Y; Makita, Y; Matsuo, M; Miki, Y; Nishizawa, S | 1 |
| Hadley, DM; Macpherson, P; Teasdale, E; Teasdale, G | 1 |
4 trial(s) available for meglumine and Pituitary Neoplasms
| Article | Year |
|---|---|
Effect of dose and field strength on enhancement with paramagnetic contrast media.
Topics: Brain Neoplasms; Cavernous Sinus; Choroid Plexus; Contrast Media; Drug Combinations; Gadolinium DTPA; Humans; Image Enhancement; Intracranial Arteriovenous Malformations; Magnetic Resonance Imaging; Maxillary Sinus; Meglumine; Organometallic Compounds; Pentetic Acid; Pituitary Gland; Pituitary Neoplasms | 1994 |
Detection of pituitary microadenomas: comparison of dynamic keyhole fast spin-echo, unenhanced, and conventional contrast-enhanced MR imaging.
Topics: Adenoma; Contrast Media; Drug Combinations; Female; Gadolinium; Gadolinium DTPA; Humans; Magnetic Resonance Imaging; Male; Meglumine; Organometallic Compounds; Pentetic Acid; Pituitary Gland; Pituitary Neoplasms; Prolactinoma | 1994 |
MR imaging of pituitary region lesions with gadodiamide injection.
Topics: Adenoma; Adult; Aged; Contrast Media; Craniopharyngioma; Drug Combinations; Female; Gadolinium; Gadolinium DTPA; Humans; Image Enhancement; Injections, Intravenous; Magnetic Resonance Imaging; Male; Meglumine; Middle Aged; Organometallic Compounds; Pentetic Acid; Pituitary Diseases; Pituitary Neoplasms; Prolactinoma; Retrospective Studies | 1994 |
Pituitary microadenomas. Does Gadolinium enhance their demonstration?
Topics: Adenoma; Adult; Clinical Trials as Topic; Drug Combinations; Drug Evaluation; Female; Gadolinium DTPA; Humans; Image Enhancement; Magnetic Resonance Imaging; Male; Meglumine; Middle Aged; Organometallic Compounds; Pentetic Acid; Pituitary Neoplasms; Prospective Studies; Tomography, X-Ray Computed | 1989 |
16 other study(ies) available for meglumine and Pituitary Neoplasms
| Article | Year |
|---|---|
Ultra-high field magnetic resonance imaging for localization of corticotropin-secreting pituitary adenomas.
Topics: ACTH-Secreting Pituitary Adenoma; Contrast Media; Female; Humans; Magnetic Resonance Imaging; Male; Meglumine; Organometallic Compounds; Pituitary Neoplasms; Prospective Studies | 2020 |
Usefulness of the dynamic gadolinium-enhanced magnetic resonance imaging with simultaneous acquisition of coronal and sagittal planes for detection of pituitary microadenomas.
Topics: Adenoma; Adolescent; Adult; Aged; Contrast Media; Female; Gadolinium DTPA; Humans; Magnetic Resonance Imaging; Male; Meglumine; Middle Aged; Organometallic Compounds; Pituitary Neoplasms; Retrospective Studies | 2012 |
Computed axial tomography of pituitary adenomas.
Topics: Adenoma; Adolescent; Adult; Aged; Child; Child, Preschool; Diagnosis, Differential; Empty Sella Syndrome; Female; Humans; Infant; Iodamide; Iodipamide; Male; Meglumine; Middle Aged; Pituitary Neoplasms; Sella Turcica; Tomography, X-Ray Computed | 1981 |
MR of pituitary metastasis in a patient with diabetes insipidus.
Topics: Aged; Carcinoma, Small Cell; Contrast Media; Diabetes Insipidus; Drug Combinations; Fatal Outcome; Gadolinium DTPA; Humans; Lung Neoplasms; Magnetic Resonance Imaging; Male; Meglumine; Organometallic Compounds; Pentetic Acid; Pituitary Gland; Pituitary Neoplasms | 1995 |
Membrane depolarization inhibits Kv1.5 voltage-gated K+ channel gene transcription and protein expression in pituitary cells.
Topics: Amiloride; Animals; Calcium; Clone Cells; Down-Regulation; Gene Expression; Kv1.5 Potassium Channel; Meglumine; Membrane Potentials; Nifedipine; Nimodipine; Pituitary Neoplasms; Potassium Channels; Potassium Channels, Voltage-Gated; Potassium Chloride; Protein Biosynthesis; Rats; RNA, Messenger; Sodium; Sodium-Hydrogen Exchangers; Transcription, Genetic; Tumor Cells, Cultured | 1995 |
Lymphocytic adenohypophysitis: contrast-enhanced MR imaging in five cases.
Topics: Adenoma; Adolescent; Adult; Autoimmune Diseases; Contrast Media; Diagnosis, Differential; Drug Combinations; Female; Gadolinium; Gadolinium DTPA; Heterocyclic Compounds; Humans; Lymphocytes; Magnetic Resonance Imaging; Male; Meglumine; Organometallic Compounds; Pentetic Acid; Pituitary Diseases; Pituitary Gland, Anterior; Pituitary Neoplasms; Retrospective Studies | 1995 |
Craniopharyngiomas--the utility of contrast medium enhancement for MR imaging at 1.5 T.
Topics: Adolescent; Adult; Child; Child, Preschool; Contrast Media; Craniopharyngioma; Drug Combinations; Female; Gadolinium; Gadolinium DTPA; Humans; Magnetic Resonance Imaging; Male; Meglumine; Middle Aged; Optic Chiasm; Organometallic Compounds; Pentetic Acid; Pituitary Neoplasms | 1994 |
MR-appearance of the pituitary gland before and after resection of pituitary macroadenomas.
Topics: Adenoma; Adult; Aged; Contrast Media; Drug Combinations; Female; Gadolinium DTPA; Humans; Magnetic Resonance Imaging; Male; Meglumine; Middle Aged; Organometallic Compounds; Pentetic Acid; Pituitary Gland; Pituitary Neoplasms; Postoperative Care; Preoperative Care; Prolactinoma; Retrospective Studies | 1994 |
MR of corticotropin-secreting pituitary microadenomas.
Topics: Adenoma; Adolescent; Adrenocorticotropic Hormone; Adult; Contrast Media; Cushing Syndrome; Drug Combinations; Female; Gadolinium; Gadolinium DTPA; Humans; Image Enhancement; Injections, Intravenous; Magnetic Resonance Imaging; Male; Meglumine; Middle Aged; Organometallic Compounds; Pentetic Acid; Pituitary Gland; Pituitary Neoplasms; Retrospective Studies; Sensitivity and Specificity | 1994 |
A clinical and histopathological study of factors affecting MRI signal intensities of pituitary adenomas.
Topics: Adenoma; Adrenocorticotropic Hormone; Adult; Aged; Cell Count; Contrast Media; Drug Combinations; Female; Follicle Stimulating Hormone; Gadolinium DTPA; Growth Hormone; Humans; Luteinizing Hormone; Magnetic Resonance Imaging; Male; Meglumine; Middle Aged; Organometallic Compounds; Paraneoplastic Endocrine Syndromes; Pentetic Acid; Pituitary Gland; Pituitary Neoplasms; Prolactin; Prolactinoma; Thyrotropin | 1994 |
Rathke cleft cysts: correlation of enhanced MR and surgical findings.
Topics: Adenoma; Adolescent; Adult; Aged; Contrast Media; Craniopharyngioma; Cysts; Diagnosis, Differential; Drug Combinations; Female; Gadolinium DTPA; Humans; Magnetic Resonance Imaging; Male; Meglumine; Middle Aged; Organometallic Compounds; Pentetic Acid; Pituitary Neoplasms; Retrospective Studies; Sella Turcica | 1994 |
Varied microcirculation of pituitary adenomas at rapid, dynamic, contrast-enhanced MR imaging.
Topics: Adenoma; Adult; Aged; Carotid Arteries; Cavernous Sinus; Contrast Media; Drug Combinations; Gadolinium; Gadolinium DTPA; Humans; Image Enhancement; Magnetic Resonance Imaging; Meglumine; Microcirculation; Middle Aged; Organometallic Compounds; Pentetic Acid; Pituitary Gland; Pituitary Neoplasms; Time Factors | 1993 |
MR differentiation of adamantinous and squamous-papillary craniopharyngiomas.
Topics: Adolescent; Adult; Calcinosis; Child; Child, Preschool; Contrast Media; Craniopharyngioma; Diagnosis, Differential; Drug Combinations; Female; Gadolinium DTPA; Humans; Magnetic Resonance Imaging; Male; Meglumine; Middle Aged; Neoplasm Recurrence, Local; Organometallic Compounds; Pentetic Acid; Pituitary Gland; Pituitary Neoplasms; Retrospective Studies; Sella Turcica | 1997 |
Long-term octreotide therapy in growth hormone-secreting pituitary adenomas: evaluation with serial MR.
Topics: Acromegaly; Adenoma; Adult; Aged; Antineoplastic Agents, Hormonal; Contrast Media; Drug Combinations; Evaluation Studies as Topic; Female; Follow-Up Studies; Gadolinium; Gadolinium DTPA; Hemorrhage; Human Growth Hormone; Humans; Image Enhancement; Insulin-Like Growth Factor I; Magnetic Resonance Imaging; Male; Meglumine; Middle Aged; Necrosis; Octreotide; Organometallic Compounds; Pentetic Acid; Pituitary Gland; Pituitary Neoplasms; Remission Induction | 1997 |
Cystic fluid in craniopharyngiomas: MR imaging and quantitative analysis.
Topics: Adolescent; Adult; Cholesterol; Contrast Media; Craniopharyngioma; Drug Combinations; Exudates and Transudates; Female; Gadolinium DTPA; Humans; Magnetic Resonance Imaging; Male; Meglumine; Methemoglobin; Middle Aged; Organometallic Compounds; Pentetic Acid; Pituitary Neoplasms; Triglycerides | 1992 |
Pituitary adenomas and normal pituitary tissue: enhancement patterns on gadopentetate-enhanced MR imaging.
Topics: Adenoma; Adult; Contrast Media; Drug Combinations; Female; Gadolinium DTPA; Humans; Magnetic Resonance Imaging; Male; Meglumine; Middle Aged; Organometallic Compounds; Pentetic Acid; Pituitary Gland; Pituitary Neoplasms; Sorbitol | 1990 |